Outcomes of Emergent Isolated Coronary Bypass Grafting in Heart Failure Patients

Giacomo Bianchi1, Edoardo Zancanaro2, Rafik Margaryan1

  • 1Department of Adult Cardiac Surgery, Ospedale del Cuore, Fondazione Toscana G. Monasterio, Via Aurelia Sud, 54100 Massa, Italy.

Life (Basel, Switzerland)
|December 23, 2022
PubMed

Insights

Patients with heart failure (HF) undergoing emergency coronary artery bypass grafting (CABG) after acute myocardial infarction (AMI) have similar in-hospital mortality to those without HF. However, HF patients face higher risks for cardiogenic shock and long-term mortality.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Critical Care Medicine

Background:

  • Patients with pre-existing heart failure (HF) face increased risks of morbidity and mortality following hospitalization for acute myocardial infarction (AMI).
  • Emergent coronary artery bypass grafting (CABG) is a critical intervention for acute coronary syndromes, but outcomes in patients with comorbid HF require further investigation.

Purpose of the Study:

  • To analyze the time trends in emergent CABG incidence for patients with and without HF.
  • To compare clinical characteristics, outcomes, and mortality risk factors for surgical revascularization in these groups.
  • To evaluate short- and medium-term prognoses after emergent CABG in patients with and without HF.

Main Methods:

  • A single-center retrospective observational study included patients undergoing isolated emergency CABG between January 2009 and January 2020.
  • Propensity-score matching created two comparable groups: patients with (n=215) and without (n=215) HF.
  • Statistical analyses assessed in-hospital and short- to medium-term outcomes, including mortality risk factors.

Main Results:

  • In-hospital mortality rates were similar between groups (2.8%; p > 0.9).
  • Patients with HF more frequently presented with cardiogenic shock.
  • Mechanical circulatory support (OR 16.7) and postoperative acute renal failure (OR 15.9) were associated with mortality.
  • Mid-term mortality was linked to HF (HR 3.47), NSTEMI, and advanced age (HR 1.28).

Conclusions:

  • Emergent CABG provides a favorable immediate prognosis for patients with acute coronary syndromes, even those with chronic heart failure.
  • While in-hospital outcomes are comparable, heart failure patients require vigilant monitoring for complications like cardiogenic shock and acute renal failure.
  • Long-term survival after surgical revascularization is influenced by the presence of heart failure and patient age.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
22
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
25
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
23